Optegra first to use cataract laser in UK

Article

Optegra is the first to offer the LensAR cataract laser in its London eye hospital.

Optegra is the first to offer the LensAR cataract laser in its London eye hospital.

The LensAR system, launched by Topcon, will be operated by a team of consultant ophthalmic surgeons led by Director of Laser Cataract Surgery for Optegra, Sundeep Kheterpal.

CE-marked and user-friendly, the system has a servo-controlled docking system that features a 'no corneal touch' liquid patient interface. This reportedly improves patient comfort and avoids compression and distortion to the cornea.

Mr Kheterpal commented, "Optegra has invested in this latest equipment to ensure we continue to offer the best possible service to our patients. Suitable for treatment of patients having both cataract surgery and Clarivu permanent lens replacement, the LensAR system has been designed to enhance the accuracy of surgery."

"The advantages of LensAR include full 3D custom imaging (CSI) of each individual eye, both posterior and anterior, to ensure precision and reproducibility. This enables the laser technology to perform laser incisions, which are more consistent and precise than ever before. The imaging is fully automated and there are multiple screens for ultimate accuracy and detail, leading to a most highly-informed diagnosis and accurate surgical procedure."

Optometrists and physicians wishing to offer their patients this cataract laser treatment are welcome to contact Hospital Manager Farzam Jafari, Optegra Eye Hospital, London, on +44 800 358 0825.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.